Prions  by Hope, Jim
The above-ground parts of most
plants are cloaked in hundreds of tiny
projections, known as trichomes.
These structures vary in function,
shape, size and spacing from species
to species, and it’s not known
whether similar cellular
differentiation programs are
responsible for making trichomes in
different plants. Trichomes are clearly
visible in the scanning electron
micrograph of a wild-type Nicotiana
tabacum seedling above (bottom left).
Petal epidermis is textured by
different projections, called floral
papillae, which are shown above at
middle left. When the transcription
factor MIXTA (which regulates
papillae in Antirrhinum majus) is
over-expressed in Nicotiana, petal
papillae elongate to produce
trichome-like structures and seedling
leaves produce extra trichomes, as
shown in the right-hand images.
Although these specialized
epidermal cells have nearly opposite
functions — floral papillae attract
pollinators by enhancing pigment
perception, whereas leaf trichomes
probably discourage hungry insects
— these results suggest that, in
Nicotiana, similar pathways regulate
their development. For more details,
see Payne T. et al., Development 1999,
126:671-682. Images reproduced
with permission from Development
and provided by Thomas Payne,
Institute for Cellular and Molecular
Biology, University of Texas at




Also known as…  proteinaceous
infectious particles and slow, or
unconventional, viruses.
What are they? Prions are the
causative agents of the transmissible
spongiform encephalopathies (TSEs).
We owe mad cow disease (bovine
spongiform encephalopathy; BSE)
and the human equivalent, new
variant Creutzfeldt–Jakob disease, to
one strain of these infectious little
molecules but the most common TSE
by far is scrapie, a neurodegenerative
affliction of sheep and goats. As far as
we know, only mammals seem to be
susceptible to these diseases. So, no
mad chickens yet.
Not to be confused with… Antarctic,
fairy, thin-billed or broad-billed
prions (South Atlantic seabirds) or
the wreckfish (Polyprion americanus),
sole member of the Polyprionidae.
Does anyone really know what a prion is?
Yes, Reed Wickner, a yeast geneticist,
does. His definition of the prion
encompasses not only mammalian
disease agents but also proteins that
allow non-Mendalian inheritance of
certain traits in yeast and fungi. But
the term really belongs to Stan
Prusiner of UCSF, winner of the
1998 Nobel Prize for Physiology or
Medicine, who resurrected
J.S. Griffiths’ 1967 idea of an
infectious protein. After years in the
intellectual wilderness, he gave this
idea the West Coast treatment, re-
packaged it as the ‘prion hypothesis’,
and never looked back. Crucially, he
also discovered a candidate protein,
PrP, and a great deal else.
So what is PrP? In its most common
form, PrPC, this 208-amino-acid




membranes by a single glycolipid
anchor. But it is also found in
lymphoid tissue and, at relatively
high concentrations, as a free-floating
monomeric protein in blood. This
form is not infectious, nor does it
seem to cause any harm. It’s PrPSc,
the abnormal isoform of PrP, that does
the damage. This is the form found
associated with the disease, and the
infectious agent, which is relatively
insoluble and resistant to proteolysis.
How different are PrPC and PrPSc? Not
very. Perhaps they differ by only a
minor twist or turn of their
polypeptide chains but dogma has it
the interchange of PrPC to PrPSc is
self-perpetuating, with twisted PrPSc
serving as a template for the demonic
conversion of PrPC. The conversion
can be produced in the test tube but
it is not autocatalytic in vitro, and the
‘new PrPSc’ has not yet been shown
to be infectious in vivo. NMR
spectroscopy has given us a picture
of PrPC but the structure of PrPSc
and the mechanism of conversion
remain unknown.
But it’s easy to tell them apart, isn’t it?
Last year it was simpler. Now, the
convenient criteria used to distinguish
‘non-infectious’ from ‘infectious’
— relative protease-resistance and
insolubility — have been demolished.
In one recent study, a ‘soluble’ PrPSc
of 106 amino-acids was genetically
engineered in transgenic mice. In
another study, a highly infectious
prion strain obtained from a patient
with a rare human TSE (Gerstmann–
Staussler–Scheinker syndrome)
transmitted a TSE-like disease to
mice without noticeably changing
their normal prion protein. Confused?
Join the growing club of people who
now doubt the classical description
of the infectious agent as ‘PrPSc, a
proteinase-resistant protein’ and are
looking for other factors.
So what does PrP do? Who knows?
The protein binds copper and might
serve as a copper transport protein in
the cellular response to oxidative
stress. But it’s one of the many
proteins that can be ‘knocked-out’ in
transgenic mice without gross adverse
effects. The mice eat, drink and mate
to their heart’s content, although
some have trouble sleeping and
remembering things … typical
research students, actually. But most
critically, the mice can’t develop prion
diseases and they can’t replicate the
infectious agent. And, yes, someone
has patented a PrP knockout cow,
with a view to curbing BSE.
Most likely to be mentioned by… Stan
Prusiner (of course), Charles
Weissmann and Adriano Aguzzi, but
the word prion has been shunned by
Alan Dickinson, discoverer of the
murine prion protein gene, Sinc.
With Hugh Fraser, he was the first to
produce rigorous criteria for typing
different strains of sheep scrapie
agent. Their criteria are based on the
brain pathology and incubation times
generated by these scrapie strains in
mice of differing Sinc genotypes.
Their methods were also critical in
showing that BSE and new variant
CJD are caused by a similar strain of
agent. The lack of a molecular
explanation for the variety of TSE
strains continues to be a thorn in the
side of those who believe a single
protein could be the infectious agent.
Can we cure new variant CJD or any
prion disease? Sadly, no. Pentosan
sulphate seems to be the most
promising prophylactic agent (in
mice, that is) but no compound has
yet been effective in humans.
Where can I find out more?
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One of the most important
challenges for neurobiologists is to
understand how neural circuits
process and represent information,
and one of the most intensively
studied neural circuits is the retina.
This outpost of the brain carries out
the first steps in the conversion of
light into vision.
Analyzing a neural circuit involves
understanding at least four aspects of
the circuit, all of which can be looked
at in the retina. First, the information
going in and coming out must be
clearly defined. Working with the
retina, the input (light) can be
precisely quantified and manipulated
experimentally. Simultaneously, the
output that is sent back to the brain
can be monitored. Second, the
neurons that make up the circuit and
their connections must be identified.
The retina consists of five classes of
neuron with two basic stages of
synaptic connection (Figure 1).
Third, the signals that pass through
the circuit should be measurable.
The electrical responses to light have
been recorded from all major classes
of neuron in the retina and recent
advances have made it possible to do
this in many neurons simultaneously.
Finally, it should be possible to
investigate the contribution of
individual elements in the circuit in
isolation. Most classes of retinal
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